{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:10:42Z","timestamp":1794604242342,"version":"4.9.1"},"reference-count":291,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["874790"],"award-info":[{"award-number":["874790"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["874790"],"award-info":[{"award-number":["874790"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["874790"],"award-info":[{"award-number":["874790"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Res"],"abstract":"<jats:title>\n                    <jats:bold>Abstract<\/jats:bold>\n                  <\/jats:title>\n                  <jats:p>Bone fractures represent a significant global healthcare burden. Although fractures typically heal on their own, some fail to regenerate properly, leading to nonunion, a condition that causes prolonged disability, morbidity, and mortality. The challenge of treating nonunion fractures is further complicated in patients with underlying bone disorders where systemic and local factors impair bone healing. Traditional treatment approaches, including autografts, allografts, xenografts, and synthetic biomaterials, face limitations such as donor site pain, immune rejection, and insufficient mechanical strength, underscoring the need for alternative strategies. Biologic therapies have emerged as promising tools to enhance bone regeneration by leveraging the body\u2019s natural healing processes. This review explores the critical role of conventional and emerging biologics in fracture healing. We categorize biologic therapies into protein-based treatments, gene and transcript therapies, small molecules, peptides, and cell-based therapies, highlighting their mechanisms of action, advantages, and clinical relevance. Finally, we examine the potential applications of biologics in treating fractures associated with bone disorders such as osteoporosis, osteogenesis imperfecta, rickets, osteomalacia, Paget\u2019s disease, and bone tumors. By integrating biologic therapies with existing biomaterial-based strategies, these innovative approaches have the potential to transform clinical management and improve outcomes for patients with difficult-to-heal fractures.<\/jats:p>","DOI":"10.1038\/s41413-025-00487-0","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T03:27:07Z","timestamp":1768188427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Biologics for bone regeneration: advances in cell, protein, gene, and mRNA therapies"],"prefix":"10.1038","volume":"14","author":[{"given":"Claudia","family":"Del Toro Runzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0484-4847","authenticated-orcid":false,"given":"Elizabeth R.","family":"Balmayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-9881","authenticated-orcid":false,"given":"Martijn","family":"van Griensven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"487_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"Collaborators, G. M. D","year":"2022","unstructured":"Collaborators, G. M. D Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry 9, 137\u2013150 (2022).","journal-title":"Lancet Psychiatry"},{"key":"487_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.injury.2011.03.046","volume":"42","author":"G Calori","year":"2011","unstructured":"Calori, G., Mazza, E., Colombo, M., Ripamonti, C. & Tagliabue, L. Treatment of long bone non-unions with polytherapy: indications and clinical results. Injury 42, 587\u2013590 (2011).","journal-title":"Injury"},{"key":"487_CR3","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/S0020-1383(07)80005-2","volume":"38","author":"JPM Fr\u00f6lke","year":"2007","unstructured":"Fr\u00f6lke, J. P. M. & Patka, P. Definition and classification of fracture non-unions. Injury 38, S19\u2013S22 (2007).","journal-title":"Injury"},{"key":"487_CR4","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S0020-1383(15)30049-8","volume":"46","author":"E Santolini","year":"2015","unstructured":"Santolini, E., West, R. & Giannoudis, P. V. Risk factors for long bone fracture non-union: a stratification approach based on the level of the existing scientific evidence. Injury 46, S8\u2013S19 (2015).","journal-title":"Injury"},{"key":"487_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bone.2013.01.005","volume":"53","author":"M Mathieu","year":"2013","unstructured":"Mathieu, M. et al. Decreased pool of mesenchymal stem cells is associated with altered chemokines serum levels in atrophic nonunion fractures. Bone 53, 391\u2013398 (2013).","journal-title":"Bone"},{"key":"487_CR6","first-page":"964","volume":"92","author":"RP Heaney","year":"1978","unstructured":"Heaney, R. P., Recker, R. R. & Saville, P. D. Menopausal changes in bone remodeling. J. Lab. Clin. Med. 92, 964\u2013970 (1978).","journal-title":"J. Lab. Clin. Med."},{"key":"487_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1080\/14653240903079385","volume":"11","author":"P Coipeau","year":"2009","unstructured":"Coipeau, P. et al. Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients. Cytotherapy 11, 584\u2013594 (2009).","journal-title":"Cytotherapy"},{"key":"487_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/jbmr.5650050402","volume":"5","author":"EF Eriksen","year":"1990","unstructured":"Eriksen, E. F. et al. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J. Bone Miner. Res. 5, 311\u2013319 (1990).","journal-title":"J. Bone Miner. Res."},{"key":"487_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/17453674.2017.1321351","volume":"88","author":"LA Mills","year":"2017","unstructured":"Mills, L. A., Aitken, S. A. & Simpson, A. H. R. The risk of non-union per fracture: current myths and revised figures from a population of over 4 million adults. Acta Orthop. 88, 434\u2013439 (2017).","journal-title":"Acta Orthop."},{"key":"487_CR10","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00264-008-0709-6","volume":"33","author":"Z Dahabreh","year":"2009","unstructured":"Dahabreh, Z., Calori, G., Kanakaris, N., Nikolaou, V. & Giannoudis, P. A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7. Int. Orthop. 33, 1407\u20131414 (2009).","journal-title":"Int. Orthop."},{"key":"487_CR11","first-page":"BR24","volume":"16","author":"VT Athanasiou","year":"2009","unstructured":"Athanasiou, V. T. et al. Histological comparison of autograft, allograft-DBM, xenograft, and synthetic grafts in a trabecular bone defect: an experimental study in rabbits. Med. Sci. Monit. 16, BR24\u2013BR31 (2009).","journal-title":"Med. Sci. Monit."},{"key":"487_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10856-020-06364-y","volume":"31","author":"HF Pereira","year":"2020","unstructured":"Pereira, H. F., Cengiz, I. F., Silva, F. S., Reis, R. L. & Oliveira, J. M. Scaffolds and coatings for bone regeneration. J. Mater. Sci. Mater. Med 31, 27 (2020).","journal-title":"J. Mater. Sci. Mater. Med"},{"key":"487_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.injury.2006.08.055","volume":"38","author":"Z Dahabreh","year":"2007","unstructured":"Dahabreh, Z., Dimitriou, R. & Giannoudis, P. V. Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7. Injury 38, 371\u2013377 (2007).","journal-title":"Injury"},{"key":"487_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3109\/17453671003587127","volume":"81","author":"L Paul","year":"2010","unstructured":"Paul, L. et al. Selection of massive bone allografts using shape-matching 3-dimensional registration. Acta Orthop. 81, 250\u2013255 (2010).","journal-title":"Acta Orthop."},{"key":"487_CR15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/jor.22635","volume":"32","author":"D Putzer","year":"2014","unstructured":"Putzer, D., Cora\u00e7a-Huber, D., Wurm, A., Schmoelz, W. & Nogler, M. Optimizing the grain size distribution of allografts in bone impaction grafting. J. Orthop. Res. 32, 1024\u20131029 (2014).","journal-title":"J. Orthop. Res."},{"key":"487_CR16","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1089\/ten.tea.2011.0645","volume":"18","author":"L Coquelin","year":"2012","unstructured":"Coquelin, L. et al. In vivo and in vitro comparison of three different allografts vitalized with human mesenchymal stromal cells. Tissue Eng. Part A 18, 1921\u20131931 (2012).","journal-title":"Tissue Eng. Part A"},{"key":"487_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3109\/07853899309147303","volume":"25","author":"HT Aro","year":"1993","unstructured":"Aro, H. T. & Aho, A. J. Clinical use of bone allografts. Ann. Med. 25, 403\u2013412 (1993).","journal-title":"Ann. Med."},{"key":"487_CR18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1708-8208.2011.00407.x","volume":"15","author":"Y Kim","year":"2013","unstructured":"Kim, Y., Nowzari, H. & Rich, S. K. Risk of prion disease transmission through bovine-derived bone substitutes: a systematic review. Clin. Implant Dent. Relat. Res. 15, 645\u2013653 (2013).","journal-title":"Clin. Implant Dent. Relat. Res."},{"key":"487_CR19","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1016\/j.injury.2016.10.025","volume":"47","author":"I Pountos","year":"2016","unstructured":"Pountos, I. & Giannoudis, P. V. Is there a role of coral bone substitutes in bone repair?. Injury 47, 2606\u20132613 (2016).","journal-title":"Injury"},{"key":"487_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/0885328216682672","volume":"31","author":"LS Bertol","year":"2017","unstructured":"Bertol, L. S., Schabbach, R. & dos Santos, L. A. L. Dimensional evaluation of patient-specific 3D printing using calcium phosphate cement for craniofacial bone reconstruction. J. Biomater. Appl. 31, 799\u2013806 (2017).","journal-title":"J. Biomater. Appl."},{"key":"487_CR21","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/jbm.a.36245","volume":"106","author":"I Lodoso-Torrecilla","year":"2018","unstructured":"Lodoso-Torrecilla, I. et al. Multimodal pore formation in calcium phosphate cements. J. Biomed. Mater. Res. A 106, 500\u2013509 (2018).","journal-title":"J. Biomed. Mater. Res. A"},{"key":"487_CR22","first-page":"83","volume":"64","author":"J Stanovici","year":"2016","unstructured":"Stanovici, J. et al. Bone regeneration strategies with bone marrow stromal cells in orthopaedic surgery. Curr. Res. Transl. Med. 64, 83\u201390 (2016).","journal-title":"Curr. Res. Transl. Med."},{"key":"487_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fbioe.2015.00009","volume":"3","author":"ER Balmayor","year":"2015","unstructured":"Balmayor, E. R. & Van Griensven, M. Gene therapy for bone engineering. Front. Bioeng. Biotechnol. 3, 9 (2015).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"487_CR24","doi-asserted-by":"crossref","unstructured":"Eftekhari, Z. et al. Advancements and challenges in mRNA and ribonucleoprotein-based therapies: from delivery systems to clinical applications. Mol. Ther.-Nucleic Acids 35, 102313 (2024).","DOI":"10.1016\/j.omtn.2024.102313"},{"key":"487_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2021.04.009","volume":"236","author":"RE De la Vega","year":"2021","unstructured":"De la Vega, R. E. et al. Gene therapy for bone healing: lessons learned and new approaches. Transl. Res. 236, 1\u201316 (2021).","journal-title":"Transl. Res."},{"key":"487_CR26","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","volume":"27","author":"PS Kowalski","year":"2019","unstructured":"Kowalski, P. S., Rudra, A., Miao, L. & Anderson, D. G. Delivering the messenger: advances in technologies for therapeutic mRNA delivery. Mol. Ther. 27, 710\u2013728 (2019).","journal-title":"Mol. Ther."},{"key":"487_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/rb\/rbw008","volume":"3","author":"J Yin","year":"2016","unstructured":"Yin, J. & Luan, S. Opportunities and challenges for the development of polymer-based biomaterials and medical devices. Regen. Biomater. 3, 129\u2013135 (2016).","journal-title":"Regen. Biomater."},{"key":"487_CR28","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s11095-006-9180-5","volume":"24","author":"W Li","year":"2007","unstructured":"Li, W. & Szoka, F. C. Lipid-based nanoparticles for nucleic acid delivery. Pharm. Res. 24, 438\u2013449 (2007).","journal-title":"Pharm. Res."},{"key":"487_CR29","first-page":"90","volume":"6","author":"T Ghassemi","year":"2018","unstructured":"Ghassemi, T. et al. Current concepts in scaffolding for bone tissue engineering. Arch. bone Jt. Surg. 6, 90 (2018).","journal-title":"Arch. bone Jt. Surg."},{"key":"487_CR30","doi-asserted-by":"crossref","unstructured":"Sfeir, C., Ho, L., Doll, B. A., Azari, K. & Hollinger, J. O. in Bone Regeneration and Repair 21\u201344 (Springer, 2005).","DOI":"10.1385\/1-59259-863-3:021"},{"key":"487_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12306-008-0064-1","volume":"92","author":"V Devescovi","year":"2008","unstructured":"Devescovi, V., Leonardi, E., Ciapetti, G. & Cenni, E. Growth factors in bone repair. La Chirurgia Degli Organ. di Mov. 92, 161\u2013168 (2008).","journal-title":"La Chirurgia Degli Organ. di Mov."},{"key":"487_CR32","doi-asserted-by":"crossref","unstructured":"Katagiri, T., Tsukamoto, S., Osawa, K. & Kokabu, S. in A Tissue Regeneration Approach to Bone and Cartilage Repair 1\u201315 (Springer, 2015).","DOI":"10.1007\/978-3-319-13266-2_1"},{"key":"487_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s007760050010","volume":"5","author":"A Ozaki","year":"2000","unstructured":"Ozaki, A., Tsunoda, M., Kinoshita, S. & Saura, R. Role of fracture hematoma and periosteum during fracture healing in rats: interaction of fracture hematoma and the periosteum in the initial step of the healing process. J. Orthop. Sci. 5, 64\u201370 (2000).","journal-title":"J. Orthop. Sci."},{"key":"487_CR34","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00441-011-1205-7","volume":"347","author":"K Schmidt-Bleek","year":"2012","unstructured":"Schmidt-Bleek, K. et al. Inflammatory phase of bone healing initiates the regenerative healing cascade. Cell tissue Res. 347, 567\u2013573 (2012).","journal-title":"Cell tissue Res."},{"key":"487_CR35","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/jbmr.5650100818","volume":"10","author":"TA Einhorn","year":"1995","unstructured":"Einhorn, T. A., Majeska, R. J., Rush, E. B., Levine, P. M. & Horowitz, M. C. The expression of cytokine activity by fracture callus. J. Bone Miner. Res. 10, 1272\u20131281 (1995).","journal-title":"J. Bone Miner. Res."},{"key":"487_CR36","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/stem.103","volume":"27","author":"F Granero-Molt\u00f3","year":"2009","unstructured":"Granero-Molt\u00f3, F. et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem cells 27, 1887\u20131898 (2009).","journal-title":"Stem cells"},{"key":"487_CR37","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/sctm.17-0039","volume":"6","author":"H Zhang","year":"2017","unstructured":"Zhang, H. et al. Acceleration of fracture healing by overexpression of basic fibroblast growth factor in the mesenchymal stromal cells. Stem Cells Transl. Med. 6, 1880\u20131893 (2017).","journal-title":"Stem Cells Transl. Med."},{"key":"487_CR38","doi-asserted-by":"publisher","first-page":"101616","DOI":"10.1016\/j.bonr.2022.101616","volume":"17","author":"J Kodama","year":"2022","unstructured":"Kodama, J., Wilkinson, K. J., Iwamoto, M., Otsuru, S. & Enomoto-Iwamoto, M. The role of hypertrophic chondrocytes in regulation of the cartilage-to-bone transition in fracture healing. Bone Rep. 17, 101616 (2022).","journal-title":"Bone Rep."},{"key":"487_CR39","doi-asserted-by":"publisher","first-page":"144855","DOI":"10.1016\/j.gene.2020.144855","volume":"754","author":"S Vimalraj","year":"2020","unstructured":"Vimalraj, S. Alkaline phosphatase: structure, expression and its function in bone mineralization. Gene 754, 144855 (2020).","journal-title":"Gene"},{"key":"487_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2020.100740","volume":"14","author":"S Ghimire","year":"2021","unstructured":"Ghimire, S. et al. The investigation of bone fracture healing under intramembranous and endochondral ossification. Bone Rep. 14, 100740 (2021).","journal-title":"Bone Rep."},{"key":"487_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41421-024-00689-6","volume":"10","author":"S Zhu","year":"2024","unstructured":"Zhu, S., Chen, W., Masson, A. & Li, Y.-P. Cell signaling and transcriptional regulation of osteoblast lineage commitment, differentiation, bone formation, and homeostasis. Cell Discov. 10, 71 (2024).","journal-title":"Cell Discov."},{"key":"487_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0736-0266(02)00087-6","volume":"21","author":"JL Ford","year":"2003","unstructured":"Ford, J. L., Robinson, D. E. & Scammell, B. E. The fate of soft callus chondrocytes during long bone fracture repair. J. Orthop. Res. 21, 54\u201361 (2003).","journal-title":"J. Orthop. Res."},{"key":"487_CR43","unstructured":"Buckwalter, J. Healing of the musculoskeletal tissues. Rockwood and Green\u2019s fractures in adults (1991)."},{"key":"487_CR44","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/00003086-199810001-00003","volume":"355","author":"TA Einhorn","year":"1998","unstructured":"Einhorn, T. A. The cell and molecular biology of fracture healing. Clin. Orthop. Relat. Res.\u00ae 355, S7\u2013S21 (1998).","journal-title":"Clin. Orthop. Relat. Res.\u00ae"},{"key":"487_CR45","doi-asserted-by":"crossref","unstructured":"Moucha, C. S. & Einhorn, T. A. in Bone Regeneration and Repair 169\u2013194 (Springer, 2005).","DOI":"10.1385\/1-59259-863-3:169"},{"key":"487_CR46","doi-asserted-by":"crossref","unstructured":"Schlickewei, C. W. et al. Current and future concepts for the treatment of impaired fracture healing. Int. J. Mol. Sci. 20, 5805 (2019).","DOI":"10.3390\/ijms20225805"},{"key":"487_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.biomaterials.2016.02.018","volume":"87","author":"ER Balmayor","year":"2016","unstructured":"Balmayor, E. R. et al. Chemically modified RNA induces osteogenesis of stem cells and human tissue explants as well as accelerates bone healing in rats. Biomaterials 87, 131\u2013146 (2016).","journal-title":"Biomaterials"},{"key":"487_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fbioe.2018.00105","volume":"6","author":"JR Perez","year":"2018","unstructured":"Perez, J. R. et al. Tissue engineering and cell-based therapies for fractures and bone defects. Front. Bioeng. Biotechnol. 6, 105 (2018).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"487_CR49","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.2106\/00004623-200308000-00017","volume":"85","author":"H Cheng","year":"2003","unstructured":"Cheng, H. et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). JBJS 85, 1544\u20131552 (2003).","journal-title":"JBJS"},{"key":"487_CR50","first-page":"587","volume":"14","author":"Z Liu","year":"1999","unstructured":"Liu, Z., Luyten, F., Lammens, J. & Dequeker, J. Molecular signaling in bone fracture healing and distraction osteogenesis. Histol. Histopathol. 14, 587\u2013595 (1999).","journal-title":"Histol. Histopathol."},{"key":"487_CR51","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S8756-3282(98)00056-8","volume":"22","author":"T Onishi","year":"1998","unstructured":"Onishi, T. et al. Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone 22, 605\u2013612 (1998).","journal-title":"Bone"},{"key":"487_CR52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3181\/00379727-200-43410A","volume":"200","author":"ME Bolander","year":"1992","unstructured":"Bolander, M. E. Regulation of fracture repair by growth factors. Proc. Soc. Exp. Biol. Med. 200, 165\u2013170 (1992).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"487_CR53","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1172\/JCI44762","volume":"121","author":"M Murakami","year":"2011","unstructured":"Murakami, M. et al. FGF-dependent regulation of VEGF receptor 2 expression in mice. J. Clin. Invest. 121, 2668\u20132678 (2011).","journal-title":"J. Clin. Invest."},{"key":"487_CR54","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1002\/jcb.21589","volume":"103","author":"T Naganawa","year":"2008","unstructured":"Naganawa, T. et al. Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice. J. Cell. Biochem. 103, 1975\u20131988 (2008).","journal-title":"J. Cell. Biochem."},{"key":"487_CR55","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/nm.3668","volume":"20","author":"H Xie","year":"2014","unstructured":"Xie, H. et al. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat. Med. 20, 1270\u20131278 (2014).","journal-title":"Nat. Med."},{"key":"487_CR56","doi-asserted-by":"publisher","DOI":"10.34133\/research.0086","volume":"6","author":"F Wang","year":"2023","unstructured":"Wang, F. et al. PDGFR in PDGF-BB\/PDGFR signaling pathway does orchestrates osteogenesis in a temporal manner. Research 6, 0086 (2023).","journal-title":"Research"},{"key":"487_CR57","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/jor.21462","volume":"29","author":"AI Caplan","year":"2011","unstructured":"Caplan, A. I. & Correa, D. PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. J. Orthop. Res. 29, 1795\u20131803 (2011).","journal-title":"J. Orthop. Res."},{"key":"487_CR58","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/ID.0000000000000580","volume":"26","author":"JCS de Oliveira","year":"2017","unstructured":"de Oliveira, J. C. S. et al. Evaluation of the osteoinductive effect of PDGF-BB associated with different carriers in bone regeneration in bone surgical defects in rats. Implant Dent. 26, 559\u2013566 (2017).","journal-title":"Implant Dent."},{"key":"487_CR59","doi-asserted-by":"publisher","first-page":"6159","DOI":"10.1007\/s00784-021-03915-7","volume":"25","author":"HJ Kim","year":"2021","unstructured":"Kim, H. J. et al. In ovariectomy-induced osteoporotic rat models, BMP-2 substantially reversed an impaired alveolar bone regeneration whereas PDGF-BB failed. Clin. Oral. Investig. 25, 6159\u20136170 (2021).","journal-title":"Clin. Oral. Investig."},{"key":"487_CR60","doi-asserted-by":"publisher","first-page":"045008","DOI":"10.1088\/1748-6041\/10\/4\/045008","volume":"10","author":"C Del Rosario","year":"2015","unstructured":"Del Rosario, C., Rodriguez-Evora, M., Reyes, R., Delgado, A. & Evora, C. BMP-2, PDGF-BB, and bone marrow mesenchymal cells in a macroporous \u03b2-TCP scaffold for critical-size bone defect repair in rats. Biomed. Mater. 10, 045008 (2015).","journal-title":"Biomed. Mater."},{"key":"487_CR61","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1038\/boneres.2016.9","volume":"4","author":"M Wu","year":"2016","unstructured":"Wu, M., Chen, G. & Li, Y.-P. TGF-\u03b2 and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 4, 16009 (2016).","journal-title":"Bone Res."},{"key":"487_CR62","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1097\/00006534-200005000-00018","volume":"105","author":"DS Steinbrech","year":"2000","unstructured":"Steinbrech, D. S. et al. Gene expression of TGF-\u03b2, TGF-\u03b2 receptor, and extracellular matrix proteins during membranous bone healing in rats. Plast. Reconstr. Surg. 105, 2028\u20132038 (2000).","journal-title":"Plast. Reconstr. Surg."},{"key":"487_CR63","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.injury.2011.03.055","volume":"42","author":"K Sarahrudi","year":"2011","unstructured":"Sarahrudi, K. et al. Elevated transforming growth factor-beta 1 (TGF-\u03b21) levels in human fracture healing. Injury 42, 833\u2013837 (2011).","journal-title":"Injury"},{"key":"487_CR64","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1146\/annurev.cb.06.110190.003121","volume":"6","author":"J Massague","year":"1990","unstructured":"Massague, J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6, 597\u2013641 (1990).","journal-title":"Annu. Rev. Cell Biol."},{"key":"487_CR65","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/nm.2793","volume":"18","author":"L Xian","year":"2012","unstructured":"Xian, L. et al. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat. Med. 18, 1095 (2012).","journal-title":"Nat. Med."},{"key":"487_CR66","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF01321886","volume":"53","author":"J Andrew","year":"1993","unstructured":"Andrew, J., Hoyland, J., Freemont, A. & Marsh, D. Insulinlike growth factor gene expression in human fracture callus. Calcif. tissue Int. 53, 97\u2013102 (1993).","journal-title":"Calcif. tissue Int."},{"key":"487_CR67","doi-asserted-by":"publisher","first-page":"T115","DOI":"10.1530\/JME-17-0298","volume":"61","author":"S Yakar","year":"2018","unstructured":"Yakar, S., Werner, H. & Rosen, C. J. 40 YEARS OF IGF1: Insulin-like growth factors: actions on the skeleton. J. Mol. Endocrinol. 61, T115\u2013T137 (2018).","journal-title":"J. Mol. Endocrinol."},{"key":"487_CR68","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/00003086-200009000-00033","volume":"378","author":"J Street","year":"2000","unstructured":"Street, J. et al. Is human fracture hematoma inherently angiogenic? Clin. Orthop. Relat. Res. 378, 224\u2013237 (2000).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"487_CR69","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/labinvest.3700053","volume":"84","author":"M Ancelin","year":"2004","unstructured":"Ancelin, M. et al. Vascular endothelial growth factor VEGF189 induces human neutrophil chemotaxis in extravascular tissue via an autocrine amplification mechanism. Lab. Invest. 84, 502\u2013512 (2004).","journal-title":"Lab. Invest."},{"key":"487_CR70","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1073\/pnas.1221602110","volume":"110","author":"MM Martino","year":"2013","unstructured":"Martino, M. M., Briquez, P. S., Ranga, A., Lutolf, M. P. & Hubbell, J. A. Heparin-binding domain of fibrin (ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc. Natl. Acad. Sci. 110, 4563\u20134568 (2013).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"487_CR71","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bone.2016.06.013","volume":"91","author":"K Hu","year":"2016","unstructured":"Hu, K. & Olsen, B. R. The roles of vascular endothelial growth factor in bone repair and regeneration. Bone 91, 30\u201338 (2016).","journal-title":"Bone"},{"key":"487_CR72","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11420-009-9129-4","volume":"6","author":"B Beamer","year":"2010","unstructured":"Beamer, B., Hettrich, C. & Lane, J. Vascular endothelial growth factor: an essential component of angiogenesis and fracture healing. HSS J. 6, 85\u201394 (2010).","journal-title":"HSS J."},{"key":"487_CR73","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/17453679808999059","volume":"69","author":"BL Grills","year":"1998","unstructured":"Grills, B. L. & Schuijers, J. A. Immunohistochemical localization of nerve growth factor in fractured and unfractured rat bone. Acta Orthop. Scand. 69, 415\u2013419 (1998).","journal-title":"Acta Orthop. Scand."},{"key":"487_CR74","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0306-4522(93)90588-7","volume":"54","author":"M Hukkanen","year":"1993","unstructured":"Hukkanen, M. et al. Rapid proliferation of calcitonin gene-related peptide-immunoreactive nerves during healing of rat tibial fracture suggests neural involvement in bone growth and remodelling. Neuroscience 54, 969\u2013979 (1993).","journal-title":"Neuroscience"},{"key":"487_CR75","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1172\/JCI128428","volume":"129","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. Fracture repair requires TrkA signaling by skeletal sensory nerves. J. Clin. Invest. 129, 5137\u20135150 (2019).","journal-title":"J. Clin. Invest."},{"key":"487_CR76","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11914-023-00844-0","volume":"22","author":"RS Parker","year":"2024","unstructured":"Parker, R. S. et al. Role of the neurologic system in fracture healing: an extensive review. Curr. Osteoporos. Rep. 22, 205\u2013216 (2024).","journal-title":"Curr. Osteoporos. Rep."},{"key":"487_CR77","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00003086-199806000-00028","volume":"351","author":"JE Madsen","year":"1998","unstructured":"Madsen, J. E. et al. Fracture healing and callus innervation after peripheral nerve resection in rats. Clin. Orthop. Relat. Res. 351, 230\u2013240 (1998).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"487_CR78","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/17453679408995457","volume":"65","author":"L Nordsletten","year":"1994","unstructured":"Nordsletten, L. et al. The neuronal regulation of fracture healing: effects of sciatic nerve resection in rat tibia. Acta Orthop. Scand. 65, 299\u2013304 (1994).","journal-title":"Acta Orthop. Scand."},{"key":"487_CR79","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1042\/CBI20110618","volume":"36","author":"GM Taghi","year":"2012","unstructured":"Taghi, G. M., Maryam, G. K., Taghi, L., Leili, H. & Leyla, M. Characterization of in vitro cultured bone marrow and adipose tissue-derived mesenchymal stem cells and their ability to express neurotrophic factors. Cell Biol. Int. 36, 1239\u20131249 (2012).","journal-title":"Cell Biol. Int."},{"key":"487_CR80","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1006\/bbrc.1994.1127","volume":"198","author":"T Nakanishi","year":"1994","unstructured":"Nakanishi, T. et al. Expression of nerve growth factor family neurotrophins in a mouse osteoblastic cell line. Biochem. Biophys. Res. Commun. 198, 891\u2013897 (1994).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"487_CR81","doi-asserted-by":"publisher","first-page":"e0222602","DOI":"10.1371\/journal.pone.0222602","volume":"14","author":"CJ Stapledon","year":"2019","unstructured":"Stapledon, C. J. et al. Human osteocyte expression of nerve growth factor: the effect of pentosan polysulphate sodium (PPS) and implications for pain associated with knee osteoarthritis. PLoS One 14, e0222602 (2019).","journal-title":"PLoS One"},{"key":"487_CR82","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5706359","volume":"2016","author":"S Takano","year":"2016","unstructured":"Takano, S. et al. Nerve growth factor regulation by TNF-\u03b1 and IL-1\u03b2 in synovial macrophages and fibroblasts in osteoarthritic mice. J. Immunol. Res. 2016, 5706359 (2016).","journal-title":"J. Immunol. Res."},{"key":"487_CR83","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/jor.20658","volume":"27","author":"R Li","year":"2009","unstructured":"Li, R., Stewart, D. J., von Schroeder, H. P., Mackinnon, E. S. & Schemitsch, E. H. Effect of cell-based VEGF gene therapy on healing of a segmental bone defect. J. Orthop. Res. 27, 8\u201314 (2009).","journal-title":"J. Orthop. Res."},{"key":"487_CR84","unstructured":"Vukicevic, S., Sampath, K. T., Grgurevic, L., Cohen, C. & Opperman, H. (Google Patents, 2019)."},{"key":"487_CR85","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3171\/2014.10.SPINE14338","volume":"23","author":"KS Cahill","year":"2015","unstructured":"Cahill, K. S., McCormick, P. C. & Levi, A. D. A comprehensive assessment of the risk of bone morphogenetic protein use in spinal fusion surgery and postoperative cancer diagnosis. J. Neurosurg. Spine 23, 86\u201393 (2015).","journal-title":"J. Neurosurg. Spine"},{"key":"487_CR86","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/ten.teb.2015.0357","volume":"22","author":"AW James","year":"2016","unstructured":"James, A. W. et al. A review of the clinical side effects of bone morphogenetic protein-2. Tissue Eng. B Rev. 22, 284\u2013297 (2016).","journal-title":"Tissue Eng. B Rev."},{"key":"487_CR87","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2217\/rme-2021-0049","volume":"16","author":"Y Kuroda","year":"2021","unstructured":"Kuroda, Y. et al. Recombinant human FGF-2 for the treatment of early-stage osteonecrosis of the femoral head: TRION, a single-arm, multicenter, Phase II trial. Regen. Med. 16, 535\u2013548 (2021).","journal-title":"Regen. Med."},{"key":"487_CR88","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/jor.20315","volume":"25","author":"H Kawaguchi","year":"2007","unstructured":"Kawaguchi, H. et al. Local application of recombinant human fibroblast growth factor-2 on bone repair: a dose\u2013escalation prospective trial on patients with osteotomy. J. Orthop. Res. 25, 480\u2013487 (2007).","journal-title":"J. Orthop. Res."},{"key":"487_CR89","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1902\/jop.2003.74.9.1282","volume":"74","author":"M Nevins","year":"2003","unstructured":"Nevins, M., Camelo, M., Nevins, M. L., Schenk, R. K. & Lynch, S. E. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone. J. Periodontol. 74, 1282\u20131292 (2003).","journal-title":"J. Periodontol."},{"key":"487_CR90","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.fcl.2016.07.009","volume":"21","author":"A Younger","year":"2016","unstructured":"Younger, A., Penner, M. & Montijo, H. E. Vancouver experience of recombinant human platelet-derived growth factor. Foot Ankle Clin. 21, 771\u2013776 (2016).","journal-title":"Foot Ankle Clin."},{"key":"487_CR91","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.2106\/JBJS.15.00879","volume":"98","author":"CW DiGiovanni","year":"2016","unstructured":"DiGiovanni, C. W. et al. The importance of sufficient graft material in achieving foot or ankle fusion. JBJS 98, 1260\u20131267 (2016).","journal-title":"JBJS"},{"key":"487_CR92","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/jbmr.4420","volume":"36","author":"MS Haines","year":"2021","unstructured":"Haines, M. S. et al. Sequential therapy with recombinant human IGF-1 followed by risedronate increases spine bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled trial. J. Bone Miner. Res. 36, 2116\u20132126 (2021).","journal-title":"J. Bone Miner. Res."},{"key":"487_CR93","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1902\/jop.1997.68.12.1186","volume":"68","author":"TH Howell","year":"1997","unstructured":"Howell, T. H. et al. A phase I\/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J. Periodontol. 68, 1186\u20131193 (1997).","journal-title":"J. Periodontol."},{"key":"487_CR94","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1902\/jop.2005.76.12.2205","volume":"76","author":"M Nevins","year":"2005","unstructured":"Nevins, M. et al. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J. Periodontol. 76, 2205\u20132215 (2005).","journal-title":"J. Periodontol."},{"key":"487_CR95","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1002\/art.24879","volume":"60","author":"KG Saag","year":"2009","unstructured":"Saag, K. G. et al. Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six\u2013month results of a randomized, double-blind, controlled trial. Arthritis Rheumatism 60, 3346\u20133355 (2009).","journal-title":"Arthritis Rheumatism"},{"key":"487_CR96","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer, R. M. et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344, 1434\u20131441 (2001).","journal-title":"N. Engl. J. Med."},{"key":"487_CR97","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.bone.2005.02.002","volume":"36","author":"S Komatsubara","year":"2005","unstructured":"Komatsubara, S. et al. Human parathyroid hormone (1\u201334) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. Bone 36, 678\u2013687 (2005).","journal-title":"Bone"},{"key":"487_CR98","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1359\/jbmr.2001.16.5.925","volume":"16","author":"F Cosman","year":"2001","unstructured":"Cosman, F. et al. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal. J. Bone Miner. Res. 16, 925\u2013931 (2001).","journal-title":"J. Bone Miner. Res."},{"key":"487_CR99","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4158\/EP14315.OR","volume":"21","author":"EE Mancilla","year":"2015","unstructured":"Mancilla, E. E., Brodsky, J. L., Mehta, S., Pignolo, R. J. & Levine, M. A. Teriparatide as a systemic treatment for lower extremity nonunion fractures: a case series. Endocr. Pract. 21, 136\u2013142 (2015).","journal-title":"Endocr. Pract."},{"key":"487_CR100","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00198-009-1061-4","volume":"21","author":"S Chintamaneni","year":"2010","unstructured":"Chintamaneni, S., Finzel, K. & Gruber, B. Successful treatment of sternal fracture nonunion with teriparatide. Osteoporos. Int. 21, 1059\u20131063 (2010).","journal-title":"Osteoporos. Int."},{"key":"487_CR101","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00590-018-2269-9","volume":"29","author":"I Kastirr","year":"2019","unstructured":"Kastirr, I. et al. Therapy of aseptic nonunions with parathyroid hormone. Eur. J. Orthop. Surg. Traumatol. 29, 169\u2013173 (2019).","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"key":"487_CR102","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/17453674.2015.1073050","volume":"87","author":"T Johansson","year":"2016","unstructured":"Johansson, T. PTH 1-34 (teriparatide) may not improve healing in proximal humerus fractures: a randomized, controlled study of 40 patients. Acta Orthop. 87, 79\u201382 (2016).","journal-title":"Acta Orthop."},{"key":"487_CR103","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1007\/s11999-015-4669-z","volume":"474","author":"M Bhandari","year":"2016","unstructured":"Bhandari, M. et al. Does teriparatide improve femoral neck fracture healing: results from a randomized placebo-controlled trial. Clin. Orthop. Relat. Res. 474, 1234\u20131244 (2016).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"487_CR104","doi-asserted-by":"publisher","first-page":"28","DOI":"10.11138\/ccmbm\/2017.14.1.028","volume":"14","author":"E Ciurlia","year":"2017","unstructured":"Ciurlia, E., Leali, P. T. & Doria, C. Use of teriparatide off-label: our experience and review of literature. Clin. Cases Miner. Bone Metab. 14, 28 (2017).","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"487_CR105","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1359\/jbmr.070802","volume":"22","author":"JB Kim","year":"2007","unstructured":"Kim, J. B. et al. Bone regeneration is regulated by Wnt signaling. J. Bone Miner. Res. 22, 1913\u20131923 (2007).","journal-title":"J. Bone Miner. Res."},{"key":"487_CR106","doi-asserted-by":"publisher","first-page":"101780","DOI":"10.1016\/j.bonr.2024.101780","volume":"22","author":"M Hadjiargyrou","year":"2024","unstructured":"Hadjiargyrou, M., Kotsiopriftis, M., Lauzier, D., Hamdy, R. C. & Kloen, P. Activation of Wnt signaling in human fracture callus and nonunion tissues. Bone Rep. 22, 101780 (2024).","journal-title":"Bone Rep."},{"key":"487_CR107","doi-asserted-by":"publisher","first-page":"29ra30","DOI":"10.1126\/scitranslmed.3000231","volume":"2","author":"S Minear","year":"2010","unstructured":"Minear, S. et al. Wnt proteins promote bone regeneration. Sci. Transl. Med. 2, 29ra30\u201329ra30 (2010).","journal-title":"Sci. Transl. Med."},{"key":"487_CR108","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/jor.22636","volume":"32","author":"PK Suen","year":"2014","unstructured":"Suen, P. K. et al. Sclerostin monoclonal antibody enhanced bone fracture healing in an open osteotomy model in rats. J. Orthop. Res. 32, 997\u20131005 (2014).","journal-title":"J. Orthop. Res."},{"key":"487_CR109","doi-asserted-by":"publisher","first-page":"526","DOI":"10.52312\/jdrs.2021.82661","volume":"32","author":"T Uemura","year":"2021","unstructured":"Uemura, T. et al. Bone healing of distal radius nonunion treated with bridge plating with bone graft substitutes in combination with systemic romosozumab administration: a case report. Jt. Dis. Relat. Surg. 32, 526 (2021).","journal-title":"Jt. Dis. Relat. Surg."},{"key":"487_CR110","first-page":"e25","volume":"27","author":"A Shakeri","year":"2020","unstructured":"Shakeri, A. & Adanty, C. Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: a review. J. Popul. Ther. 27, e25\u2013e31 (2020).","journal-title":"J. Popul. Ther."},{"key":"487_CR111","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.2106\/JBJS.19.01008","volume":"102","author":"M Bhandari","year":"2020","unstructured":"Bhandari, M. et al. Romosozumab in skeletally mature adults with a fresh unilateral tibial diaphyseal fracture: a randomized phase-2 study. JBJS 102, 1416\u20131426 (2020).","journal-title":"JBJS"},{"key":"487_CR112","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2106\/JBJS.19.00790","volume":"102","author":"EH Schemitsch","year":"2020","unstructured":"Schemitsch, E. H. et al. A randomized, placebo-controlled study of romosozumab for the treatment of hip fractures. JBJS 102, 693\u2013702 (2020).","journal-title":"JBJS"},{"key":"487_CR113","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/34848","volume":"391","author":"A Glinka","year":"1998","unstructured":"Glinka, A. et al. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391, 357\u2013362 (1998).","journal-title":"Nature"},{"key":"487_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2474-11-210","volume":"11","author":"JS Butler","year":"2010","unstructured":"Butler, J. S. et al. Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation. BMC Musculoskelet. Disord. 11, 1\u201310 (2010).","journal-title":"BMC Musculoskelet. Disord."},{"key":"487_CR115","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.bone.2011.02.008","volume":"48","author":"F Agholme","year":"2011","unstructured":"Agholme, F., Isaksson, H., Kuhstoss, S. & Aspenberg, P. The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions. Bone 48, 988\u2013996 (2011).","journal-title":"Bone"},{"key":"487_CR116","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bone.2014.07.039","volume":"71","author":"H Jin","year":"2015","unstructured":"Jin, H. et al. Anti-DKK1 antibody promotes bone fracture healing through activation of \u03b2-catenin signaling. Bone 71, 63\u201375 (2015).","journal-title":"Bone"},{"key":"487_CR117","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"D Lacey","year":"1998","unstructured":"Lacey, D. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165\u2013176 (1998).","journal-title":"Cell"},{"key":"487_CR118","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/1759720X15579189","volume":"7","author":"O T\u00f6rring","year":"2015","unstructured":"T\u00f6rring, O. Effects of denosumab on bone density, mass and strength in women with postmenopausal osteoporosis. Ther. Adv. Musculoskelet. Dis. 7, 88\u2013102 (2015).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"487_CR119","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00198-015-3234-7","volume":"26","author":"S Papapoulos","year":"2015","unstructured":"Papapoulos, S. et al. The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study. Osteoporos. Int. 26, 2773\u20132783 (2015).","journal-title":"Osteoporos. Int."},{"key":"487_CR120","doi-asserted-by":"publisher","first-page":"35","DOI":"10.18579\/jopcr\/v23.1.38","volume":"23","author":"P Shiva","year":"2024","unstructured":"Shiva, P. Effect of denosumab injection in early union and consolidation of callus in aseptic tibial shaft non-union. J. Pharm. Res. 23, 35 (2024).","journal-title":"J. Pharm. Res."},{"key":"487_CR121","doi-asserted-by":"crossref","unstructured":"Garrison, K. R. et al. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Health Technology Assessment (Winchester, England) 11, 1\u2013150, iii (2007).","DOI":"10.3310\/hta11300"},{"key":"487_CR122","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/S0020-1383(07)80012-X","volume":"38","author":"N Kanakaris","year":"2007","unstructured":"Kanakaris, N. & Giannoudis, P. V. The health economics of the treatment of long-bone non-unions. Injury 38, S77\u2013S84 (2007).","journal-title":"Injury"},{"key":"487_CR123","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2174\/138920111794295693","volume":"12","author":"M Kamionka","year":"2011","unstructured":"Kamionka, M. Engineering of therapeutic proteins production in Escherichia coli. Curr. Pharm. Biotechnol. 12, 268\u2013274 (2011).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"487_CR124","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jconrel.2019.02.016","volume":"301","author":"R Zaman","year":"2019","unstructured":"Zaman, R. et al. Current strategies in extending half-lives of therapeutic proteins. J. Control. Release 301, 176\u2013189 (2019).","journal-title":"J. Control. Release"},{"key":"487_CR125","doi-asserted-by":"publisher","first-page":"123407","DOI":"10.1016\/j.ijbiomac.2023.123407","volume":"233","author":"A Beygmoradi","year":"2023","unstructured":"Beygmoradi, A., Homaei, A., Hemmati, R. & Fernandes, P. Recombinant protein expression: challenges in production and folding related matters. Int. J. Biol. Macromol. 233, 123407 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"487_CR126","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.RVW.20.00220","volume":"9","author":"CH Evans","year":"2021","unstructured":"Evans, C. H., Ghivizzani, S. C. & Robbins, P. D. Orthopaedic gene therapy: twenty-five years on. JBJS Rev. 9, e20 (2021).","journal-title":"JBJS Rev."},{"key":"487_CR127","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/10611860412331285260","volume":"12","author":"GA Rao","year":"2004","unstructured":"Rao, G. A. & Buethe, D. D. Plasmid based gene delivery for orthopedic disorders: a brief review. J. Drug Target. 12, 341\u2013345 (2004).","journal-title":"J. Drug Target."},{"key":"487_CR128","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/sj.gt.3301960","volume":"10","author":"J Park","year":"2003","unstructured":"Park, J. et al. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther. 10, 1089\u20131098 (2003).","journal-title":"Gene Ther."},{"key":"487_CR129","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/jgm.1331","volume":"11","author":"K Osawa","year":"2009","unstructured":"Osawa, K., Okubo, Y., Nakao, K., Koyama, N. & Bessho, K. Osteoinduction by microbubble-enhanced transcutaneous sonoporation of human bone morphogenetic protein-2. J. Gene Med. 11, 633\u2013641 (2009).","journal-title":"J. Gene Med."},{"key":"487_CR130","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2106\/00004623-200305000-00020","volume":"85","author":"JC Wang","year":"2003","unstructured":"Wang, J. C. et al. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. JBJS 85, 905\u2013911 (2003).","journal-title":"JBJS"},{"key":"487_CR131","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1258\/002367702320389134","volume":"36","author":"M Van Griensven","year":"2002","unstructured":"Van Griensven, M. et al. Adenoviral gene transfer in a rat fracture model. Lab. Anim. 36, 455\u2013461 (2002).","journal-title":"Lab. Anim."},{"key":"487_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.626315","volume":"9","author":"P Wilkinson","year":"2021","unstructured":"Wilkinson, P. et al. Systematic review of the preclinical technology readiness of orthopedic gene therapy and outlook for clinical translation. Front. Bioeng. Biotechnol. 9, 626315 (2021).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"487_CR133","first-page":"8648949","volume":"2016","author":"I Bozo","year":"2016","unstructured":"Bozo, I., Deev, R., Drobyshev, A., Isaev, A. & Eremin, I. World\u2019s first clinical case of gene-activated bone substitute application. Case Rep. Dent. 2016, 8648949 (2016).","journal-title":"Case Rep. Dent."},{"key":"487_CR134","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/term.3363","volume":"16","author":"F Ranjbarnejad","year":"2022","unstructured":"Ranjbarnejad, F., Khazaei, M., Shahryari, A., Khazaei, F. & Rezakhani, L. Recent advances in gene therapy for bone tissue engineering. J. Tissue Eng. Regen. Med. 16, 1121\u20131137 (2022).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"487_CR135","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12668-016-0325-7","volume":"7","author":"R Masgutov","year":"2017","unstructured":"Masgutov, R. et al. Use of gene-activated demineralized bone allograft in the therapy of ulnar pseudarthrosis. Case report. BioNanoScience 7, 194\u2013198 (2017).","journal-title":"BioNanoScience"},{"key":"487_CR136","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/jcp.23031","volume":"227","author":"CH Evans","year":"2012","unstructured":"Evans, C. H., Ghivizzani, S. & Robbins, P. D. Orthopedic gene therapy\u2014lost in translation?. J. Cell. Physiol. 227, 416\u2013420 (2012).","journal-title":"J. Cell. Physiol."},{"key":"487_CR137","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.injury.2010.11.016","volume":"42","author":"E Argintar","year":"2011","unstructured":"Argintar, E., Edwards, S. & Delahay, J. Bone morphogenetic proteins in orthopaedic trauma surgery. Injury 42, 730\u2013734 (2011).","journal-title":"Injury"},{"key":"487_CR138","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1302\/2046-3758.810.BJR-2019-0265","volume":"8","author":"CH Evans","year":"2019","unstructured":"Evans, C. H. The vicissitudes of gene therapy. Bone Jt. Res. 8, 469\u2013471 (2019).","journal-title":"Bone Jt. Res."},{"key":"487_CR139","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1586\/14760584.2015.973859","volume":"14","author":"D Weissman","year":"2015","unstructured":"Weissman, D. mRNA transcript therapy. Expert Rev. Vaccines 14, 265\u2013281 (2015).","journal-title":"Expert Rev. Vaccines"},{"key":"487_CR140","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-023-00977-5","volume":"30","author":"Y-S Wang","year":"2023","unstructured":"Wang, Y.-S. et al. mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications. J. Biomed. Sci. 30, 84 (2023).","journal-title":"J. Biomed. Sci."},{"key":"487_CR141","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.omtn.2019.08.001","volume":"17","author":"H Huysmans","year":"2019","unstructured":"Huysmans, H. et al. Expression kinetics and innate immune response after electroporation and LNP-mediated delivery of a self-amplifying mRNA in the skin. Mol. Ther. -Nucleic Acids 17, 867\u2013878 (2019).","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"487_CR142","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nbt.1733","volume":"29","author":"MS Kormann","year":"2011","unstructured":"Kormann, M. S. et al. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat. Biotechnol. 29, 154\u2013157 (2011).","journal-title":"Nat. Biotechnol."},{"key":"487_CR143","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/ten.tea.2018.0112","volume":"25","author":"W Zhang","year":"2019","unstructured":"Zhang, W. et al. An improved, chemically modified RNA encoding BMP-2 enhances osteogenesis in vitro and in vivo. Tissue Eng. Part A 25, 131\u2013144 (2019).","journal-title":"Tissue Eng. Part A"},{"key":"487_CR144","doi-asserted-by":"publisher","first-page":"100105","DOI":"10.1016\/j.mtbio.2021.100105","volume":"10","author":"L Andr\u00e9e","year":"2021","unstructured":"Andr\u00e9e, L., Yang, F., Brock, R. & Leeuwenburgh, S. Designing biomaterials for the delivery of RNA therapeutics to stimulate bone healing. Mater. Today Bio 10, 100105 (2021).","journal-title":"Mater. Today Bio"},{"key":"487_CR145","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.omtn.2023.05.019","volume":"32","author":"CDT Runzer","year":"2023","unstructured":"Runzer, C. D. T. et al. Cellular uptake of modified mRNA occurs via caveolae-mediated endocytosis, yielding high protein expression in slow-dividing cells. Mol. Ther. -Nucleic Acids 32, 960\u2013979 (2023).","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"487_CR146","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.actbio.2020.03.045","volume":"108","author":"P Wang","year":"2020","unstructured":"Wang, P. et al. Co-delivery of NS1 and BMP2 mRNAs to murine pluripotent stem cells leads to enhanced BMP-2 expression and osteogenic differentiation. Acta Biomater. 108, 337\u2013346 (2020).","journal-title":"Acta Biomater."},{"key":"487_CR147","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/scd.2016.0171","volume":"26","author":"ER Balmayor","year":"2017","unstructured":"Balmayor, E. R. et al. Modified mRNA for BMP-2 in combination with biomaterials serves as a transcript-activated matrix for effectively inducing osteogenic pathways in stem cells. Stem Cells Dev. 26, 25\u201334 (2017).","journal-title":"Stem Cells Dev."},{"key":"487_CR148","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1021\/acs.molpharmaceut.0c01042","volume":"18","author":"O Fayed","year":"2021","unstructured":"Fayed, O., van Griensven, M., Tahmasebi Birgani, Z., Plank, C. & Balmayor, E. R. Transcript-activated coatings on titanium mediate cellular osteogenesis for enhanced osteointegration. Mol. Pharm. 18, 1121\u20131137 (2021).","journal-title":"Mol. Pharm."},{"key":"487_CR149","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1208\/s12248-016-0034-8","volume":"19","author":"B Khorsand","year":"2017","unstructured":"Khorsand, B. et al. A comparative study of the bone regenerative effect of chemically modified RNA encoding BMP-2 or BMP-9. AAPS J. 19, 438\u2013446 (2017).","journal-title":"AAPS J."},{"key":"487_CR150","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl6242","volume":"8","author":"RE De La Vega","year":"2022","unstructured":"De La Vega, R. E. et al. Efficient healing of large osseous segmental defects using optimized chemically modified messenger RNA encoding BMP-2. Sci. Adv. 8, eabl6242 (2022).","journal-title":"Sci. Adv."},{"key":"487_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-023-00285-3","volume":"43","author":"M Zhang","year":"2023","unstructured":"Zhang, M. et al. Enhancement of bone regeneration by coadministration of angiogenic and osteogenic factors using messenger RNA. Inflamm. Regen. 43, 32 (2023).","journal-title":"Inflamm. Regen."},{"key":"487_CR152","first-page":"683","volume":"90","author":"C-L Halioua-Haubold","year":"2017","unstructured":"Halioua-Haubold, C.-L. et al. Focus: genome editing: regulatory considerations for gene therapy products in the US, EU, and Japan. Yale J. Biol. Med. 90, 683 (2017).","journal-title":"Yale J. Biol. Med."},{"key":"487_CR153","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrrheum.2015.28","volume":"11","author":"CH Evans","year":"2015","unstructured":"Evans, C. H. & Huard, J. Gene therapy approaches to regenerating the musculoskeletal system. Nat. Rev. Rheumatol. 11, 234\u2013242 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"487_CR154","first-page":"26","volume":"13","author":"B Li","year":"2018","unstructured":"Li, B. MicroRNA regulation in osteogenic and adipogenic differentiation of bone mesenchymal stem cells and its application in bone regeneration. Curr. Stem cell Res. Ther. 13, 26\u201330 (2018).","journal-title":"Curr. Stem cell Res. Ther."},{"key":"487_CR155","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2174\/1389202916666150817213630","volume":"16","author":"T Nakasa","year":"2015","unstructured":"Nakasa, T., Yoshizuka, M., Andry Usman, M., Elbadry Mahmoud, E. & Ochi, M. MicroRNAs and bone regeneration. Curr. Genomics 16, 441\u2013452 (2015).","journal-title":"Curr. Genomics"},{"key":"487_CR156","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1302\/0301-620X.107B2.BJJ-2024-0160.R3","volume":"107","author":"RV Groven","year":"2025","unstructured":"Groven, R. V. et al. Early total care and damage control orthopaedics result in partially contrasting patterns of microRNA expression at the fracture site and in the systemic circulation: an animal study. Bone Jt. J. 107, 193\u2013203 (2025).","journal-title":"Bone Jt. J."},{"key":"487_CR157","doi-asserted-by":"publisher","first-page":"8227","DOI":"10.3390\/ijms16048227","volume":"16","author":"S Fang","year":"2015","unstructured":"Fang, S., Deng, Y., Gu, P. & Fan, X. MicroRNAs regulate bone development and regeneration. Int. J. Mol. Sci. 16, 8227\u20138253 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"487_CR158","first-page":"5317","volume":"18","author":"Z Liu","year":"2018","unstructured":"Liu, Z. et al. Lentivirus-mediated microRNA-26a overexpression in bone mesenchymal stem cells facilitates bone regeneration in bone defects of calvaria in mice. Mol. Med. Rep. 18, 5317\u20135326 (2018).","journal-title":"Mol. Med. Rep."},{"key":"487_CR159","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.3390\/pharmaceutics14112302","volume":"14","author":"S Hosseinpour","year":"2022","unstructured":"Hosseinpour, S. et al. A comparative study of mesoporous silica and mesoporous bioactive glass nanoparticles as non-viral microRNA vectors for osteogenesis. Pharmaceutics 14, 2302 (2022).","journal-title":"Pharmaceutics"},{"key":"487_CR160","doi-asserted-by":"publisher","first-page":"22805","DOI":"10.1021\/acsami.2c21933","volume":"15","author":"H Kuang","year":"2023","unstructured":"Kuang, H. et al. Integrated osteoinductive Factors\u2500 Exosome@ MicroRNA-26a hydrogel enhances bone regeneration. ACS Appl. Mater. Interfaces 15, 22805\u201322816 (2023).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"487_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10376","volume":"7","author":"X Zhang","year":"2016","unstructured":"Zhang, X., Li, Y., Chen, Y. E., Chen, J. & Ma, P. X. Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects. Nat. Commun. 7, 10376 (2016).","journal-title":"Nat. Commun."},{"key":"487_CR162","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1021\/acsbiomaterials.0c01756","volume":"7","author":"MT Remy","year":"2021","unstructured":"Remy, M. T. et al. Rat calvarial bone regeneration by 3D-printed \u03b2-tricalcium phosphate incorporating microRNA-200c. ACS Biomater. Sci. Eng. 7, 4521\u20134534 (2021).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"487_CR163","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202307639","volume":"36","author":"JM Sadowska","year":"2024","unstructured":"Sadowska, J. M. et al. A multifunctional scaffold for bone infection treatment by delivery of microRNA therapeutics combined with antimicrobial nanoparticles. Adv. Mater. 36, 2307639 (2024).","journal-title":"Adv. Mater."},{"key":"487_CR164","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1218148","volume":"14","author":"M Tian","year":"2023","unstructured":"Tian, M. et al. The role of lactoferrin in bone remodeling: evaluation of its potential in targeted delivery and treatment of metabolic bone diseases and orthopedic conditions. Front. Endocrinol. 14, 1218148 (2023).","journal-title":"Front. Endocrinol."},{"key":"487_CR165","doi-asserted-by":"publisher","first-page":"e20386","DOI":"10.1371\/journal.pone.0020386","volume":"6","author":"SJ Sample","year":"2011","unstructured":"Sample, S. J., Hao, Z., Wilson, A. P. & Muir, P. Role of calcitonin gene-related peptide in bone repair after cyclic fatigue loading. PLoS One 6, e20386 (2011).","journal-title":"PLoS One"},{"key":"487_CR166","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.orthres.2004.03.009","volume":"22","author":"MR Sheller","year":"2004","unstructured":"Sheller, M. R. et al. Repair of rabbit segmental defects with the thrombin peptide, TP508. J. Orthop. Res. 22, 1094\u20131099 (2004).","journal-title":"J. Orthop. Res."},{"key":"487_CR167","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/jbm.a.30265","volume":"72","author":"EL Hedberg","year":"2005","unstructured":"Hedberg, E. L. et al. Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo. J. Biomed. Mater. Res. A. 72, 343\u2013353 (2005).","journal-title":"J. Biomed. Mater. Res. A."},{"key":"487_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-016-0646-y","volume":"14","author":"I Pountos","year":"2016","unstructured":"Pountos, I. et al. The role of peptides in bone healing and regeneration: a systematic review. BMC Med. 14, 1\u201315 (2016).","journal-title":"BMC Med."},{"key":"487_CR169","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.bbrc.2003.09.192","volume":"311","author":"H Nguyen","year":"2003","unstructured":"Nguyen, H., Qian, J. J., Bhatnagar, R. S. & Li, S. Enhanced cell attachment and osteoblastic activity by P-15 peptide-coated matrix in hydrogels. Biochem. Biophys. Res. Commun. 311, 179\u2013186 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"487_CR170","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1023\/B:JMSM.0000032818.09569.d9","volume":"15","author":"M-C Durrieu","year":"2004","unstructured":"Durrieu, M.-C. et al. Grafting RGD containing peptides onto hydroxyapatite to promote osteoblastic cells adhesion. J. Mater. Sci. Mater. Med. 15, 779\u2013786 (2004).","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"487_CR171","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/1439-7633(20000818)1:2<107::AID-CBIC107>3.0.CO;2-4","volume":"1","author":"M Kantlehner","year":"2000","unstructured":"Kantlehner, M. et al. Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. Chembiochem 1, 107\u2013114 (2000).","journal-title":"Chembiochem"},{"key":"487_CR172","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.1016\/j.biomaterials.2014.03.079","volume":"35","author":"T Hou","year":"2014","unstructured":"Hou, T. et al. A composite demineralized bone matrix\u2013self assembling peptide scaffold for enhancing cell and growth factor activity in bone marrow. Biomaterials 35, 5689\u20135699 (2014).","journal-title":"Biomaterials"},{"key":"487_CR173","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0734-9750(02)00026-5","volume":"20","author":"S Zhang","year":"2002","unstructured":"Zhang, S. Emerging biological materials through molecular self-assembly. Biotechnol. Adv. 20, 321\u2013339 (2002).","journal-title":"Biotechnol. Adv."},{"key":"487_CR174","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.4155\/fmc.13.133","volume":"5","author":"Q-Q Han","year":"2013","unstructured":"Han, Q.-Q., Du, Y. & Yang, P.-S. The role of small molecules in bone regeneration. Future Med. Chem. 5, 1671\u20131684 (2013).","journal-title":"Future Med. Chem."},{"key":"487_CR175","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.drudis.2014.01.012","volume":"19","author":"CT Laurencin","year":"2014","unstructured":"Laurencin, C. T., Ashe, K. M., Henry, N., Kan, H. M. & Lo, K. W.-H. Delivery of small molecules for bone regenerative engineering: preclinical studies and potential clinical applications. Drug Discov. Today 19, 794\u2013800 (2014).","journal-title":"Drug Discov. Today"},{"key":"487_CR176","doi-asserted-by":"crossref","unstructured":"Blaich, G., Janssen, B., Roth, G. & Salfeld, J. Overview: differentiating issues in the development of macromolecules compared with small molecules. Handbook Pharm. Biotechnol. 89\u2013123 (2007).","DOI":"10.1002\/9780470117118.ch1c"},{"key":"487_CR177","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1874764711104030153","volume":"4","author":"K WH Lo","year":"2011","unstructured":"WH Lo, K., D. Ulery, B., Deng, M., M. Ashe, K. & T. Laurencin, C. Current patents on osteoinductive molecules for bone tissue engineering. Recent Pat. Biomed. Eng. 4, 153\u2013167 (2011).","journal-title":"Recent Pat. Biomed. Eng."},{"key":"487_CR178","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2217\/rme.12.33","volume":"7","author":"KW Lo","year":"2012","unstructured":"Lo, K. W., Ashe, K. M., Kan, H. M. & Laurencin, C. T. The role of small molecules in musculoskeletal regeneration. Regen. Med. 7, 535\u2013549 (2012).","journal-title":"Regen. Med."},{"key":"487_CR179","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bbrc.2008.08.167","volume":"376","author":"H Hojo","year":"2008","unstructured":"Hojo, H. et al. Development of high-throughput screening system for osteogenic drugs using a cell-based sensor. Biochem. Biophys. Res. Commun. 376, 375\u2013379 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"487_CR180","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/bit.22925","volume":"108","author":"DM Brey","year":"2011","unstructured":"Brey, D. M. et al. High-throughput screening of a small molecule library for promoters and inhibitors of mesenchymal stem cell osteogenic differentiation. Biotechnol. Bioeng. 108, 163\u2013174 (2011).","journal-title":"Biotechnol. Bioeng."},{"key":"487_CR181","doi-asserted-by":"publisher","first-page":"e59045","DOI":"10.1371\/journal.pone.0059045","volume":"8","author":"K Vrijens","year":"2013","unstructured":"Vrijens, K. et al. Identification of small molecule activators of BMP signaling. PLoS One 8, e59045 (2013).","journal-title":"PLoS One"},{"key":"487_CR182","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-0501.2008.01630.x","volume":"20","author":"Z Du","year":"2009","unstructured":"Du, Z., Chen, J., Yan, F. & Xiao, Y. Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats. Clin. Oral. implants Res. 20, 145\u2013150 (2009).","journal-title":"Clin. Oral. implants Res."},{"key":"487_CR183","unstructured":"Yang, G. et al. Bone responses to simvastatin-loaded porous implant surfaces in an ovariectomized model. Int. J. Oral Maxillofac. Implants 27, 369\u2212374 (2012)."},{"key":"487_CR184","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1002\/jbmr.2213","volume":"29","author":"SR Montgomery","year":"2014","unstructured":"Montgomery, S. R. et al. A novel osteogenic oxysterol compound for therapeutic development to promote bone growth: activation of hedgehog signaling and osteogenesis through smoothened binding. J. Bone Miner. Res. 29, 1872\u20131885 (2014).","journal-title":"J. Bone Miner. Res."},{"key":"487_CR185","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1016\/j.biomaterials.2010.04.061","volume":"31","author":"CEP Aronin","year":"2010","unstructured":"Aronin, C. E. P. et al. The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720. Biomaterials 31, 6417\u20136424 (2010).","journal-title":"Biomaterials"},{"key":"487_CR186","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00441-011-1217-3","volume":"347","author":"C Huang","year":"2012","unstructured":"Huang, C. et al. Local delivery of FTY720 accelerates cranial allograft incorporation and bone formation. Cell Tissue Res. 347, 553\u2013566 (2012).","journal-title":"Cell Tissue Res."},{"key":"487_CR187","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/jor.22426","volume":"31","author":"A Heilmann","year":"2013","unstructured":"Heilmann, A. et al. Systemic treatment with the sphingosine-1-phosphate analog FTY720 does not improve fracture healing in mice. J. Orthop. Res. 31, 1845\u20131850 (2013).","journal-title":"J. Orthop. Res."},{"key":"487_CR188","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/00007691-199512000-00007","volume":"17","author":"A Thomson","year":"1995","unstructured":"Thomson, A., Bonham, C. & Zeevi, A. Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Ther. Drug Monit. 17, 584\u2013591 (1995).","journal-title":"Ther. Drug Monit."},{"key":"487_CR189","doi-asserted-by":"publisher","first-page":"160","DOI":"10.22203\/eCM.v040a10","volume":"40","author":"R De la Vega","year":"2020","unstructured":"De la Vega, R. et al. Effects of FK506 on the healing of diaphyseal, critical size defects in the rat femur. Eur. Cells Mater. 40, 160 (2020).","journal-title":"Eur. Cells Mater."},{"key":"487_CR190","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2106\/JBJS.L.00275","volume":"95","author":"E Wong","year":"2013","unstructured":"Wong, E. et al. A novel low-molecular-weight compound enhances ectopic bone formation and fracture repair. JBJS 95, 454\u2013461 (2013).","journal-title":"JBJS"},{"key":"487_CR191","doi-asserted-by":"publisher","first-page":"10","DOI":"10.22203\/eCM.v016a02","volume":"16","author":"VA Stadelmann","year":"2008","unstructured":"Stadelmann, V. A., Terrier, A., Gauthier, O., Bouler, J.-M. & Pioletti, D. P. Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study. Eur. Cells Mater. 16, 10\u201316 (2008).","journal-title":"Eur. Cells Mater."},{"key":"487_CR192","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41413-023-00262-z","volume":"11","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q. et al. Small-molecule amines: a big role in the regulation of bone homeostasis. Bone Res. 11, 40 (2023).","journal-title":"Bone Res."},{"key":"487_CR193","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2106\/JBJS.G.01572","volume":"90","author":"TE Patterson","year":"2008","unstructured":"Patterson, T. E., Kumagai, K., Griffith, L. & Muschler, G. F. Cellular strategies for enhancement of fracture repair. JBJS 90, 111\u2013119 (2008).","journal-title":"JBJS"},{"key":"487_CR194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4053","volume":"14","author":"MS Virk","year":"2012","unstructured":"Virk, M. S. & Lieberman, J. R. Biologic adjuvants for fracture healing. Arthritis Res. Ther. 14, 1\u201313 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"487_CR195","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/jcp.20959","volume":"211","author":"A Giordano","year":"2007","unstructured":"Giordano, A., Galderisi, U. & Marino, I. R. From the laboratory bench to the patient\u2019s bedside: an update on clinical trials with mesenchymal stem cells. J. Cell. Physiol. 211, 27\u201335 (2007).","journal-title":"J. Cell. Physiol."},{"key":"487_CR196","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4252\/wjsc.v6.i3.312","volume":"6","author":"W Tsuji","year":"2014","unstructured":"Tsuji, W., Rubin, J. P. & Marra, K. G. Adipose-derived stem cells: implications in tissue regeneration. World J. Stem Cells 6, 312 (2014).","journal-title":"World J. Stem Cells"},{"key":"487_CR197","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1089\/ten.2006.0271","volume":"13","author":"M Marcacci","year":"2007","unstructured":"Marcacci, M. et al. Stem cells associated with macroporous bioceramics for long bone repair: 6-to 7-year outcome of a pilot clinical study. Tissue Eng. 13, 947\u2013955 (2007).","journal-title":"Tissue Eng."},{"key":"487_CR198","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1056\/NEJM200102013440516","volume":"344","author":"R Quarto","year":"2001","unstructured":"Quarto, R. et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Med. 344, 385\u2013386 (2001).","journal-title":"N. Engl. J. Med."},{"key":"487_CR199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2474-10-20","volume":"10","author":"S-J Kim","year":"2009","unstructured":"Kim, S.-J. et al. A multi-center, randomized, clinical study to compare the effect and safety of autologous cultured osteoblast (Ossron\u2122) injection to treat fractures. BMC Musculoskelet. Disord. 10, 1\u20139 (2009).","journal-title":"BMC Musculoskelet. Disord."},{"key":"487_CR200","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.injury.2004.01.009","volume":"36","author":"A Goel","year":"2005","unstructured":"Goel, A., Sangwan, S., Siwach, R. & Ali, A. M. Percutaneous bone marrow grafting for the treatment of tibial non-union. Injury 36, 203\u2013206 (2005).","journal-title":"Injury"},{"key":"487_CR201","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0020-1383(01)00075-4","volume":"33","author":"J Kettunen","year":"2002","unstructured":"Kettunen, J., M\u00e4kel\u00e4, E., Turunen, V., Suomalainen, O. & Partanen, K. Percutaneous bone grafting in the treatment of the delayed union and non-union of tibial fractures. Injury 33, 239\u2013245 (2002).","journal-title":"Injury"},{"key":"487_CR202","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000516668","volume":"68","author":"H Chen","year":"2022","unstructured":"Chen, H., Liu, O., Chen, S. & Zhou, Y. Aging and mesenchymal stem cells: therapeutic opportunities and challenges in the older group. Gerontology 68, 339\u2013352 (2022).","journal-title":"Gerontology"},{"key":"487_CR203","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3390\/cells8060633","volume":"8","author":"B Widholz","year":"2019","unstructured":"Widholz, B., Tsitlakidis, S., Reible, B., Moghaddam, A. & Westhauser, F. Pooling of patient-derived mesenchymal stromal cells reduces inter-individual confounder-associated variation without negative impact on cell viability, proliferation and osteogenic differentiation. Cells 8, 633 (2019).","journal-title":"Cells"},{"key":"487_CR204","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jcyt.2019.10.001","volume":"21","author":"Y Sato","year":"2019","unstructured":"Sato, Y. et al. Tumorigenicity assessment of cell therapy products: the need for global consensus and points to consider. Cytotherapy 21, 1095\u20131111 (2019).","journal-title":"Cytotherapy"},{"key":"487_CR205","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1302\/0301-620X.91B8.22546","volume":"91","author":"J Alsousou","year":"2009","unstructured":"Alsousou, J., Thompson, M., Hulley, P., Noble, A. & Willett, K. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J. Bone Jt. Surg. Br. 91, 987\u2013996 (2009).","journal-title":"J. Bone Jt. Surg. Br."},{"key":"487_CR206","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/0363546506294078","volume":"35","author":"M S\u00e1nchez","year":"2007","unstructured":"S\u00e1nchez, M. et al. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am. J. sports Med. 35, 245\u2013251 (2007).","journal-title":"Am. J. sports Med."},{"key":"487_CR207","unstructured":"S\u00e1nchez, A. R., Sheridan, P. J. & Kupp, L. I. Is platelet-rich plasma the perfect enhancement factor? A current review. Int. J. Oral Maxillofac. Implants 18, 93\u2212103 (2003)."},{"key":"487_CR208","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1517\/14712598.2016.1118458","volume":"16","author":"A Oryan","year":"2016","unstructured":"Oryan, A., Alidadi, S. & Moshiri, A. Platelet-rich plasma for bone healing and regeneration. Expert Opin. Biol. Ther. 16, 213\u2013232 (2016).","journal-title":"Expert Opin. Biol. Ther."},{"key":"487_CR209","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1007\/s00586-011-1897-0","volume":"20","author":"J Sys","year":"2011","unstructured":"Sys, J., Weyler, J., Van Der Zijden, T., Parizel, P. & Michielsen, J. Platelet-rich plasma in mono-segmental posterior lumbar interbody fusion. Eur. Spine J. 20, 1650\u20131657 (2011).","journal-title":"Eur. Spine J."},{"key":"487_CR210","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s00264-012-1603-9","volume":"36","author":"JC Peerbooms","year":"2012","unstructured":"Peerbooms, J. C. et al. No positive bone healing after using platelet rich plasma in a skeletal defect. An observational prospective cohort study. Int. Orthop. 36, 2113\u20132119 (2012).","journal-title":"Int. Orthop."},{"key":"487_CR211","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.biomaterials.2015.05.030","volume":"61","author":"G Abagnale","year":"2015","unstructured":"Abagnale, G. et al. Surface topography enhances differentiation of mesenchymal stem cells towards osteogenic and adipogenic lineages. Biomaterials 61, 316\u2013326 (2015).","journal-title":"Biomaterials"},{"key":"487_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122398","volume":"303","author":"JM Sadowska","year":"2023","unstructured":"Sadowska, J. M. et al. Development of miR-26a-activated scaffold to promote healing of critical-sized bone defects through angiogenic and osteogenic mechanisms. Biomaterials 303, 122398 (2023).","journal-title":"Biomaterials"},{"key":"487_CR213","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.actbio.2023.03.028","volume":"162","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Sustained delivery of a heterodimer bone morphogenetic protein-2\/7 via a collagen hydroxyapatite scaffold accelerates and improves critical femoral defect healing. Acta Biomater. 162, 164\u2013181 (2023).","journal-title":"Acta Biomater."},{"key":"487_CR214","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.actbio.2012.01.009","volume":"8","author":"S Kim","year":"2012","unstructured":"Kim, S. et al. Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation. Acta Biomater. 8, 1768\u20131777 (2012).","journal-title":"Acta Biomater."},{"key":"487_CR215","doi-asserted-by":"publisher","first-page":"6840","DOI":"10.1021\/acsami.9b18496","volume":"12","author":"T Xin","year":"2020","unstructured":"Xin, T. et al. Programmed sustained release of recombinant human bone morphogenetic protein-2 and inorganic ion composite hydrogel as artificial periosteum. ACS Appl. Mater. interfaces 12, 6840\u20136851 (2020).","journal-title":"ACS Appl. Mater. interfaces"},{"key":"487_CR216","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.actbio.2018.04.030","volume":"73","author":"C Zhao","year":"2018","unstructured":"Zhao, C. et al. The role of the micro-pattern and nano-topography of hydroxyapatite bioceramics on stimulating osteogenic differentiation of mesenchymal stem cells. Acta Biomater. 73, 509\u2013521 (2018).","journal-title":"Acta Biomater."},{"key":"487_CR217","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1016\/j.biomaterials.2011.05.015","volume":"32","author":"Y Kang","year":"2011","unstructured":"Kang, Y., Kim, S., Khademhosseini, A. & Yang, Y. Creation of bony microenvironment with CaP and cell-derived ECM to enhance human bone-marrow MSC behavior and delivery of BMP-2. Biomaterials 32, 6119\u20136130 (2011).","journal-title":"Biomaterials"},{"key":"487_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2024.214167","volume":"169","author":"A Chandrakar","year":"2025","unstructured":"Chandrakar, A. et al. Melt electrowriting of hydrophilic\/hydrophobic multiblock copolymers for bone tissue regeneration. Biomater. Adv. 169, 214167 (2025).","journal-title":"Biomater. Adv."},{"key":"487_CR219","doi-asserted-by":"crossref","unstructured":"Sanchez, A. A. et al. Enhanced osteogenic differentiation in hyaluronic acid methacrylate (HAMA) matrix: a comparative study of hPDC and hBMSC spheroids for bone tissue engineering. Biofabrication 17, 025013 (2025).","DOI":"10.1088\/1758-5090\/adb2e6"},{"key":"487_CR220","doi-asserted-by":"crossref","unstructured":"van der Heide, D. et al. implementing bmp-7 chemically modified RNA for bone regeneration with 3D printable hyaluronic acid-collagen granular gels. Adv. Healthcare Mater. 14, 2405047 (2025).","DOI":"10.1002\/adhm.202405047"},{"key":"487_CR221","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cger.2016.08.003","volume":"33","author":"P Alejandro","year":"2017","unstructured":"Alejandro, P. & Constantinescu, F. A review of osteoporosis in the older adult. Clin. Geriatr. Med. 33, 27\u201340 (2017).","journal-title":"Clin. Geriatr. Med."},{"key":"487_CR222","doi-asserted-by":"crossref","unstructured":"Center, J. R. Outcomes following osteoporotic fractures. In Osteoporosis (fourth edition) 841\u2013852 (2013).","DOI":"10.1016\/B978-0-12-415853-5.00035-2"},{"key":"487_CR223","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/bph.15024","volume":"178","author":"BL Langdahl","year":"2020","unstructured":"Langdahl, B. L. Overview of treatment approaches to osteoporosis. Br. J. Pharm. 178, 1891\u20131906 (2020).","journal-title":"Br. J. Pharm."},{"key":"487_CR224","unstructured":"Office of the Surgeon General (US). Bone Health and Osteoporosis: A Report of the Surgeon General. The Burden of Bone Disease. (Rockville (MD), 2004)."},{"key":"487_CR225","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings, S. R. et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N. Engl. J. Med. 361, 756\u2013765 (2009).","journal-title":"N. Engl. J. Med."},{"key":"487_CR226","unstructured":"Lyu, Q. Therapeutic potential of nucleic acid aptamers against sclerostin in the treatment of osteoporosis, Hong Kong Baptist University, (2017)."},{"key":"487_CR227","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa1215458","volume":"368","author":"CM Laine","year":"2013","unstructured":"Laine, C. M. et al. WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta. N. Engl. J. Med. 368, 1809\u20131816 (2013).","journal-title":"N. Engl. J. Med."},{"key":"487_CR228","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fcell.2018.00170","volume":"6","author":"KS Houschyar","year":"2019","unstructured":"Houschyar, K. S. et al. Wnt pathway in bone repair and regeneration\u2013what do we know so far. Front. Cell Dev. Biol. 6, 170 (2019).","journal-title":"Front. Cell Dev. Biol."},{"key":"487_CR229","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1089\/hum.2006.17.507","volume":"17","author":"M Egermann","year":"2006","unstructured":"Egermann, M. et al. Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Hum. Gene Ther. 17, 507\u2013517 (2006).","journal-title":"Hum. Gene Ther."},{"key":"487_CR230","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1089\/hum.2018.013","volume":"29","author":"Y Zeng","year":"2018","unstructured":"Zeng, Y. et al. Gene therapy with Tetracycline-regulated human recombinant COLIA1 cDNA direct adenoviral delivery enhances fracture healing in osteoporotic rats. Hum. Gene Ther. 29, 902\u2013915 (2018).","journal-title":"Hum. Gene Ther."},{"key":"487_CR231","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.cellbi.2008.06.005","volume":"32","author":"Y Tang","year":"2008","unstructured":"Tang, Y. et al. Combination of bone tissue engineering and BMP-2 gene transfection promotes bone healing in osteoporotic rats. Cell Biol. Int. 32, 1150\u20131157 (2008).","journal-title":"Cell Biol. Int."},{"key":"487_CR232","doi-asserted-by":"publisher","first-page":"102074","DOI":"10.1016\/j.nantod.2023.102074","volume":"54","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Delivery of m7G methylated Runx2 mRNA by bone-targeted lipid nanoparticle promotes osteoblastic bone formation in senile osteoporosis. Nano Today 54, 102074 (2024).","journal-title":"Nano Today"},{"key":"487_CR233","first-page":"1307","volume":"28","author":"T Michigami","year":"2018","unstructured":"Michigami, T. Rickets\/Osteomalacia. Consensus on vitamin D deficiency and insufficiency in children. Clin. Calcium 28, 1307\u20131311 (2018).","journal-title":"Clin. Calcium"},{"key":"487_CR234","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4103\/2230-8210.93732","volume":"16","author":"M Sahay","year":"2012","unstructured":"Sahay, M. & Sahay, R. Rickets\u2013vitamin D deficiency and dependency. Indian J. Endocrinol. Metab. 16, 164 (2012).","journal-title":"Indian J. Endocrinol. Metab."},{"key":"487_CR235","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0950-351X(97)80569-1","volume":"11","author":"RM Francis","year":"1997","unstructured":"Francis, R. M. & Selby, P. L. Osteomalacia. Bailliere\u2019s. Clin. Endocrinol. Metab. 11, 145\u2013163 (1997).","journal-title":"Bailliere\u2019s. Clin. Endocrinol. Metab."},{"key":"487_CR236","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.beem.2007.09.005","volume":"22","author":"C Land","year":"2008","unstructured":"Land, C. & Schoenau, E. Fetal and postnatal bone development: reviewing the role of mechanical stimuli and nutrition. Best. Pract. Res. Clin. Endocrinol. Metab. 22, 107\u2013118 (2008).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"487_CR237","first-page":"88","volume":"9","author":"S Acar","year":"2017","unstructured":"Acar, S., Demir, K. & Shi, Y. Genetic causes of rickets. J. Clin. Res. Pediatr. Endocrinol. 9, 88 (2017).","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"487_CR238","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-019-1014-8","volume":"14","author":"SS Beck-Nielsen","year":"2019","unstructured":"Beck-Nielsen, S. S. et al. FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J. Rare Dis. 14, 1\u201325 (2019).","journal-title":"Orphanet J. Rare Dis."},{"key":"487_CR239","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1210\/clinem\/dgac433","volume":"107","author":"X Bai","year":"2022","unstructured":"Bai, X., Levental, M. & Karaplis, A. C. Burosumab treatment for autosomal recessive hypophosphatemic rickets type 1 (ARHR1). J. Clin. Endocrinol. Metab. 107, 2777\u20132783 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"487_CR240","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.metabol.2017.08.013","volume":"82","author":"E Mornet","year":"2018","unstructured":"Mornet, E. Hypophosphatasia. Metabolism 82, 142\u2013155 (2018).","journal-title":"Metabolism"},{"key":"487_CR241","doi-asserted-by":"publisher","first-page":"116778","DOI":"10.1016\/j.bone.2023.116778","volume":"172","author":"M Kang","year":"2023","unstructured":"Kang, M., Wu, M. & Crane, J. L. Asfotase alfa improved skeletal mineralization and fracture healing in a child with MCAHS. Bone 172, 116778 (2023).","journal-title":"Bone"},{"key":"487_CR242","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1210\/endo.142.7.8281","volume":"142","author":"O Dardenne","year":"2001","unstructured":"Dardenne, O., Prud\u2019homme, J. E., Arabian, A., Glorieux, F. H. & St-Arnaud, R. Targeted inactivation of the 25-hydroxyvitamin D3-1\u03b1-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142, 3135\u20133141 (2001).","journal-title":"Endocrinology"},{"key":"487_CR243","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1530\/JME-20-0089","volume":"66","author":"S Fukumoto","year":"2021","unstructured":"Fukumoto, S. FGF23-related hypophosphatemic rickets\/osteomalacia: diagnosis and new treatment. J. Mol. Endocrinol. 66, R57\u2013R65 (2021).","journal-title":"J. Mol. Endocrinol."},{"key":"487_CR244","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1359\/jbmr.1998.13.7.1061","volume":"13","author":"ES Siris","year":"1998","unstructured":"Siris, E. S. Paget\u2019s disease of bone. J. Bone Miner. Res. 13, 1061\u20131065 (1998).","journal-title":"J. Bone Miner. Res."},{"key":"487_CR245","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1359\/jbmr.2002.17.1.145","volume":"17","author":"WE Friedrichs","year":"2002","unstructured":"Friedrichs, W. E. et al. Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget\u2019s disease. J. Bone Miner. Res. 17, 145\u2013151 (2002).","journal-title":"J. Bone Miner. Res."},{"key":"487_CR246","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrendo.2015.138","volume":"11","author":"FR Singer","year":"2015","unstructured":"Singer, F. R. Paget\u2019s disease of bone\u2014genetic and environmental factors. Nat. Rev. Endocrinol. 11, 662 (2015).","journal-title":"Nat. Rev. Endocrinol."},{"key":"487_CR247","doi-asserted-by":"crossref","unstructured":"Singer, F., Schiller, A. & Pyle, E. Paget\u2019s disease of bone. Metabolic Bone Disease 2, 489\u2212575 (1978).","DOI":"10.1016\/B978-0-12-068702-2.50011-8"},{"key":"487_CR248","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1359\/jbmr.061108","volume":"22","author":"D Naot","year":"2007","unstructured":"Naot, D. et al. Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget\u2019s disease of bone. J. Bone Miner. Res. 22, 298\u2013309 (2007).","journal-title":"J. Bone Miner. Res."},{"key":"487_CR249","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s11684-011-0168-0","volume":"5","author":"Z Xia","year":"2011","unstructured":"Xia, Z., Chen, C., Chen, P., Xie, H. & Luo, X. MicroRNAs and their roles in osteoclast differentiation. Front. Med. 5, 414\u2013419 (2011).","journal-title":"Front. Med."},{"key":"487_CR250","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","volume":"387","author":"A Forlino","year":"2016","unstructured":"Forlino, A. & Marini, J. C. Osteogenesis imperfecta. Lancet 387, 1657\u20131671 (2016).","journal-title":"Lancet"},{"key":"487_CR251","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3389\/fendo.2019.00924","volume":"10","author":"SH Ralston","year":"2019","unstructured":"Ralston, S. H. & Gaston, M. S. Management of Osteogenesis Imperfecta. Front Endocrinol 10, 924 (2019).","journal-title":"Front Endocrinol"},{"key":"487_CR252","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/01202412-200511000-00013","volume":"14","author":"V Agarwal","year":"2005","unstructured":"Agarwal, V. & Joseph, B. Non-union in osteogenesis imperfecta. J. Pediatr. Orthop. B 14, 451\u2013455 (2005).","journal-title":"J. Pediatr. Orthop. B"},{"key":"487_CR253","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00223-008-9113-x","volume":"82","author":"P Roschger","year":"2008","unstructured":"Roschger, P. et al. Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations. Calcif. Tissue Int. 82, 263\u2013270 (2008).","journal-title":"Calcif. Tissue Int."},{"key":"487_CR254","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/sj.gt.3302199","volume":"11","author":"C Niyibizi","year":"2004","unstructured":"Niyibizi, C., Wang, S., Mi, Z. & Robbins, P. Gene therapy approaches for osteogenesis imperfecta. Gene Ther. 11, 408\u2013416 (2004).","journal-title":"Gene Ther."},{"key":"487_CR255","doi-asserted-by":"publisher","first-page":"8932","DOI":"10.1073\/pnas.132252399","volume":"99","author":"EM Horwitz","year":"2002","unstructured":"Horwitz, E. M. et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl. Acad. Sci. 99, 8932\u20138937 (2002).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"487_CR256","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bone.2019.04.011","volume":"124","author":"M Cardinal","year":"2019","unstructured":"Cardinal, M. et al. Sclerostin antibody reduces long bone fractures in the oim\/oim model of osteogenesis imperfecta. Bone 124, 137\u2013147 (2019).","journal-title":"Bone"},{"key":"487_CR257","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/jbmr.3143","volume":"32","author":"FH Glorieux","year":"2017","unstructured":"Glorieux, F. H. et al. BPS804 anti-sclerostin antibody in adults with moderate osteogenesis imperfecta: results of a randomized phase 2a trial. J. Bone Miner. Res. 32, 1496\u20131504 (2017).","journal-title":"J. Bone Miner. Res."},{"key":"487_CR258","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1359\/JBMR.041131","volume":"20","author":"LJ Melton III","year":"2005","unstructured":"Melton, L. J. III, Kyle, R. A., Achenbach, S. J., Oberg, A. L. & Rajkumar, S. V. Fracture risk with multiple myeloma: a population-based study. J. Bone Miner. Res. 20, 487\u2013493 (2005).","journal-title":"J. Bone Miner. Res."},{"key":"487_CR259","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.injury.2015.07.028","volume":"46","author":"DJ Bryson","year":"2015","unstructured":"Bryson, D. J., Wicks, L. & Ashford, R. U. The investigation and management of suspected malignant pathological fractures: a review for the general orthopaedic surgeon. Injury 46, 1891\u20131899 (2015).","journal-title":"Injury"},{"key":"487_CR260","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/iju.13170","volume":"23","author":"S Tsuzuki","year":"2016","unstructured":"Tsuzuki, S., Park, S. H., Eber, M. R., Peters, C. M. & Shiozawa, Y. Skeletal complications in cancer patients with bone metastases. Int. J. Urol. 23, 825\u2013832 (2016).","journal-title":"Int. J. Urol."},{"key":"487_CR261","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1007\/s12094-022-02872-1","volume":"24","author":"S Casta\u00f1eda","year":"2022","unstructured":"Casta\u00f1eda, S. et al. Bone loss induced by cancer treatments in breast and prostate cancer patients. Clin. Transl. Oncol. 24, 2090\u20132106 (2022).","journal-title":"Clin. Transl. Oncol."},{"key":"487_CR262","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-024-54877-9","volume":"15","author":"AE Hamouda","year":"2024","unstructured":"Hamouda, A. E. et al. Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity. Nat. Commun. 15, 1\u201320 (2024).","journal-title":"Nat. Commun."},{"key":"487_CR263","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-020-02109-x","volume":"19","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. A clinical study on bone defect reconstruction and functional recovery in benign bone tumors of the lower extremity, treated by bone marrow mesenchymal stem cell rapid screening\u2013enrichment\u2013composite system. World J. Surg. Oncol. 19, 1\u20137 (2021).","journal-title":"World J. Surg. Oncol."},{"key":"487_CR264","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/jor.1100130309","volume":"13","author":"MP Bostrom","year":"1995","unstructured":"Bostrom, M. P. et al. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J. Orthop. Res. 13, 357\u2013367 (1995).","journal-title":"J. Orthop. Res."},{"key":"487_CR265","doi-asserted-by":"publisher","first-page":"112466","DOI":"10.1016\/j.msec.2021.112466","volume":"130","author":"CE Gillman","year":"2021","unstructured":"Gillman, C. E. & Jayasuriya, A. C. FDA-approved bone grafts and bone graft substitute devices in bone regeneration. Mater. Sci. Eng. C. 130, 112466 (2021).","journal-title":"Mater. Sci. Eng. C."},{"key":"487_CR266","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0278-2391(88)90223-6","volume":"46","author":"BL Eppley","year":"1988","unstructured":"Eppley, B. L., Doucet, M., Connolly, D. T. & Feder, J. Enhancement of angiogenesis by bFGF in mandibular bone graft healing in the rabbit. J. oral. Maxillofac. Surg. 46, 391\u2013398 (1988).","journal-title":"J. oral. Maxillofac. Surg."},{"key":"487_CR267","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1002\/jbmr.146","volume":"25","author":"H Kawaguchi","year":"2010","unstructured":"Kawaguchi, H. et al. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo-controlled trial. J. Bone Miner. Res. 25, 2735\u20132743 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"487_CR268","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1177\/1071100715576370","volume":"36","author":"TR Daniels","year":"2015","unstructured":"Daniels, T. R. et al. Prospective randomized controlled trial of hindfoot and ankle fusions treated with rhPDGF-BB in combination with a \u03b2-TCP-collagen matrix. Foot Ankle Int. 36, 739\u2013748 (2015).","journal-title":"Foot Ankle Int."},{"key":"487_CR269","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1083\/jcb.110.6.2195","volume":"110","author":"ME Joyce","year":"1990","unstructured":"Joyce, M. E., Roberts, A. B., Sporn, M. B. & Bolander, M. E. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol. 110, 2195\u20132207 (1990).","journal-title":"J. Cell Biol."},{"key":"487_CR270","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jbmr.3871","volume":"35","author":"J Xu","year":"2020","unstructured":"Xu, J. et al. High-dose TGF-\u03b21 impairs mesenchymal stem cell\u2013mediated bone regeneration via Bmp2 inhibition. J. Bone Miner. Res. 35, 167\u2013180 (2020).","journal-title":"J. Bone Miner. Res."},{"key":"487_CR271","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1210\/jcem.87.4.8426","volume":"87","author":"S Boonen","year":"2002","unstructured":"Boonen, S. et al. Musculoskeletal effects of the recombinant human IGF-I\/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. J. Clin. Endocrinol. Metab. 87, 1593\u20131599 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"487_CR272","doi-asserted-by":"publisher","first-page":"9656","DOI":"10.1073\/pnas.152324099","volume":"99","author":"J Street","year":"2002","unstructured":"Street, J. et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc. Natl. Acad. Sci. 99, 9656\u20139661 (2002).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"487_CR273","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1172\/JCI15153","volume":"110","author":"H Peng","year":"2002","unstructured":"Peng, H. et al. Synergistic enhancement of bone formation and healing by stem cell\u2013expressed VEGF and bone morphogenetic protein-4. J. Clin. Invest. 110, 751\u2013759 (2002).","journal-title":"J. Clin. Invest."},{"key":"487_CR274","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1172\/JCI82585","volume":"126","author":"K Hu","year":"2016","unstructured":"Hu, K. & Olsen, B. R. Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. J. Clin. Invest. 126, 509\u2013526 (2016).","journal-title":"J. Clin. Invest."},{"key":"487_CR275","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/jbm.a.32403","volume":"92","author":"P Yang","year":"2010","unstructured":"Yang, P. et al. rhVEGF165 delivered in a porous \u03b2-tricalcium phosphate scaffold accelerates bridging of critical-sized defects in rabbit radii. J. Biomed. Mater. Res. A 92, 626\u2013640 (2010).","journal-title":"J. Biomed. Mater. Res. A"},{"key":"487_CR276","first-page":"1165","volume":"25","author":"L Zhang","year":"2014","unstructured":"Zhang, L. et al. Improvement in angiogenesis and osteogenesis with modified cannulated screws combined with VEGF\/PLGA\/fibrin glue in femoral neck fractures. J. Mater. Sci.: Mater. Med. 25, 1165\u20131172 (2014).","journal-title":"J. Mater. Sci.: Mater. Med."},{"key":"487_CR277","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/term.2013","volume":"11","author":"E Quinlan","year":"2017","unstructured":"Quinlan, E. et al. Controlled release of vascular endothelial growth factor from spray-dried alginate microparticles in collagen\u2013hydroxyapatite scaffolds for promoting vascularization and bone repair. J. tissue Eng. Regen. Med. 11, 1097\u20131109 (2017).","journal-title":"J. tissue Eng. Regen. Med."},{"key":"487_CR278","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78983-y","volume":"10","author":"KO Rivera","year":"2020","unstructured":"Rivera, K. O. et al. Local injections of \u03b2-NGF accelerates endochondral fracture repair by promoting cartilage to bone conversion. Sci. Rep. 10, 22241 (2020).","journal-title":"Sci. Rep."},{"key":"487_CR279","doi-asserted-by":"publisher","DOI":"10.1038\/srep15280","volume":"5","author":"Z Wang","year":"2015","unstructured":"Wang, Z. et al. A regulatory loop containing miR-26a, GSK3\u03b2 and C\/EBP\u03b1 regulates the osteogenesis of human adipose-derived mesenchymal stem cells. Sci. Rep. 5, 15280 (2015).","journal-title":"Sci. Rep."},{"key":"487_CR280","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1168-2","volume":"10","author":"C Yang","year":"2019","unstructured":"Yang, C. et al. miRNA-21 promotes osteogenesis via the PTEN\/PI3K\/Akt\/HIF-1\u03b1 pathway and enhances bone regeneration in critical size defects. Stem Cell Res. Ther. 10, 1\u201311 (2019).","journal-title":"Stem Cell Res. Ther."},{"key":"487_CR281","doi-asserted-by":"publisher","first-page":"281756","DOI":"10.1155\/2015\/281756","volume":"2015","author":"B Krist","year":"2015","unstructured":"Krist, B., Florczyk, U., Pietraszek-Gremplewicz, K., J\u00f3zkowicz, A. & Dulak, J. The role of miR-378a in metabolism, angiogenesis, and muscle biology. Int. J. Endocrinol. 2015, 281756 (2015).","journal-title":"Int. J. Endocrinol."},{"key":"487_CR282","first-page":"7249","volume":"7","author":"L You","year":"2014","unstructured":"You, L. et al. MiR-378 overexpression attenuates high glucose-suppressed osteogenic differentiation through targeting CASP3 and activating PI3K\/Akt signaling pathway. Int. J. Clin. Exp. Pathol. 7, 7249 (2014).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"487_CR283","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8402390","volume":"2018","author":"B Zhang","year":"2018","unstructured":"Zhang, B. et al. MicroRNA-378 promotes osteogenesis-angiogenesis coupling in BMMSCs for potential bone regeneration. Anal. Cell. Pathol. 2018, 8402390 (2018).","journal-title":"Anal. Cell. Pathol."},{"key":"487_CR284","first-page":"4689","volume":"23","author":"Z Tian","year":"2017","unstructured":"Tian, Z., Zhou, H., Xu, Y. & Bai, J. MicroRNA-495 inhibits new bone regeneration via targeting high mobility group AT-Hook 2 (HMGA2). Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 23, 4689 (2017).","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"487_CR285","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s42003-020-0754-2","volume":"3","author":"T Minamizaki","year":"2020","unstructured":"Minamizaki, T. et al. The matrix vesicle cargo miR-125b accumulates in the bone matrix, inhibiting bone resorption in mice. Commun. Biol. 3, 30 (2020).","journal-title":"Commun. Biol."},{"key":"487_CR286","doi-asserted-by":"crossref","unstructured":"Joris, V., Balmayor, E. R. & van Griensven, M. miR-125b differentially impacts mineralization in dexamethasone and calcium-treated human mesenchymal stem cells. Mol. Ther. Nucleic Acids 36, 102446 (2025).","DOI":"10.1016\/j.omtn.2024.102446"},{"key":"487_CR287","doi-asserted-by":"publisher","first-page":"6745","DOI":"10.3390\/ijms22136745","volume":"22","author":"S Ito","year":"2021","unstructured":"Ito, S. et al. Overexpression of miR-125b in osteoblasts improves age-related changes in bone mass and quality through suppression of osteoclast formation. Int. J. Mol. Sci. 22, 6745 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"487_CR288","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1089\/dna.2017.3936","volume":"37","author":"W Zhang","year":"2018","unstructured":"Zhang, W. et al. miRNA-133a-5p inhibits the expression of osteoblast differentiation-associated markers by targeting the 3\u2032 UTR of RUNX2. DNA Cell Biol. 37, 199\u2013209 (2018).","journal-title":"DNA Cell Biol."},{"key":"487_CR289","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.ymthe.2018.05.002","volume":"26","author":"V Miscianinov","year":"2018","unstructured":"Miscianinov, V. et al. MicroRNA-148b targets the TGF-\u03b2 pathway to regulate angiogenesis and endothelial-to-mesenchymal transition during skin wound healing. Mol. Ther. 26, 1996\u20132007 (2018).","journal-title":"Mol. Ther."},{"key":"487_CR290","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.110128","volume":"105","author":"KK Moncal","year":"2019","unstructured":"Moncal, K. K. et al. Collagen-infilled 3D printed scaffolds loaded with miR-148b-transfected bone marrow stem cells improve calvarial bone regeneration in rats. Mater. Sci. Eng. C. 105, 110128 (2019).","journal-title":"Mater. Sci. Eng. C."},{"key":"487_CR291","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12881-019-0854-3","volume":"20","author":"S Mollazadeh","year":"2019","unstructured":"Mollazadeh, S. et al. Overexpression of MicroRNA-148b-3p stimulates osteogenesis of human bone marrow-derived mesenchymal stem cells: the role of MicroRNA-148b-3p in osteogenesis. BMC Med. Genet. 20, 1\u201310 (2019).","journal-title":"BMC Med. Genet."}],"container-title":["Bone Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00487-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00487-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00487-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:31:32Z","timestamp":1768473092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00487-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":291,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["487"],"URL":"https:\/\/doi.org\/10.1038\/s41413-025-00487-0","relation":{},"ISSN":["2095-6231"],"issn-type":[{"value":"2095-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CdTR: Salary paid from the cmRNAbone project granted by the European Union\u2019s Horizon 2020 research and innovation program under the Grant Agreement No 874790. ERB: Is inventor on a patent regarding therapeutic RNA for osteogenesis: Induction of osteogenesis by delivering BMP encoding RNA, BALMAYOR, Elizabeth, RUDOLPH, Carsten, PLANK, Christian. Publication Date: 19.05.2016. Publication No.: WO\/2016\/075154. ERB\u2019s work on osteogenesis and RNA therapeutics has been partially funded by the NIH (R01 AR074395 from NIAMS). Member of the executive council of TERMIS-EU. MvG: MvG\u2019s work on osteogenesis has been partially funded by the cmRNAbone project granted by the European Union\u2019s Horizon 2020 research and innovation program under the Grant Agreement No 874790. President of the Section Research of the German Society for Orthopedics and Trauma Surgery (unpaid). Member of the scientific advisory board for CIBER-BBN in Spain (unpaid). Has received compensation as a member of the scientific advisory board for Centre for Doctoral Training in Advanced Biomedical Materials (Manchester\/Sheffield, UK).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}